Cargando…
Anti-PD-1 pembrolizumab induced autoimmune diabetes in Chinese patient: A case report
RATIONALE: Programmed cell death-1 protein (PD-1) antibody is an immune-checkpoint inhibitor that triggers anti-tumor response by enhancing immune response. Although PD-1 antibody has been reported effective in some malignant tumor, it can also induce significant immune-related adverse events (irAEs...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250450/ https://www.ncbi.nlm.nih.gov/pubmed/30407284 http://dx.doi.org/10.1097/MD.0000000000012907 |